Alphanox Co.,Ltd. (KOSDAQ: 043100)

Market Cap	23.92B
Revenue (ttm)	27.31B
Net Income (ttm)	-18.90B
Shares Out	7.97M
EPS (ttm)	-2,823.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,549
Open	3,250.00
Previous Close	3,260.00
Day's Range	2,930.00 - 3,260.00
52-Week Range	2,830.00 - 6,830.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Alphanox Co.,Ltd.

Alphanox Co.,Ltd. manufactures and sells medical devices and healthcare products in South Korea. The company offers surgical instruments, trays and containers, and disposable and custom-made devices; spine, trauma, and joint implants; and in vitro diagnostic devices. It also provides direct, dispenser, and portable type hydrogen water generators; medical devices, such as personal and functional devices, dietary supplements, beauty care products, and pillows. The company was formerly known as Solco Biomedical Co., Ltd. and changed its name to Al...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1974
• Employees: 117
• Stock Exchange: KOSDAQ
• Ticker Symbol: 043100

Financial Performance

In 2023, Alphanox Co.,Ltd.'s revenue was 26.88 billion, an increase of 14.88% compared to the previous year's 23.40 billion. Losses were -19.97 billion, 109.6% more than in 2022.